- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06453343
Clinical Trial to Compare Two Surgical Approaches to the Cochlea (BULLS-I)
Multicenter Randomized Controlled Trial Comparing Surgical Approaches to the Cochlea for the Slim Modiolar Electrode: Assessing Intracochlear Trauma Using Intraoperative Electrocochleography Measurements and Preservation of Residual Hearing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: Preserving residual hearing in cochlear implant (CI) surgery has gained significant attention. It not only signifies minimally invasive implantation but also supports natural sound perception and enables electrical-acoustic stimulation, enhancing sound localization, music appreciation, and speech recognition in noisy environments. Using the Cochlear™ Nucleus® CI with Slim Modiolar electrode (Cochlear Ltd., Sydney, Australia), potential sites of residual hearing loss in surgery include approaches to the cochlear lumen, potential damage during entry, and damage during electrode insertion. Studies comparing different surgical approaches (cochleostomy (CO) and extended round window (eRW)) show varied results. Electrocochleography (ECochG) can be used to indicate intracochlear damage during electrode insertion, however, the variability observed in ECochG responses during cochlear implantation remains significant. Moreover, ECochG has not yet been used to monitor cochlear functions throughout every phase of surgery, including the insertion of the sheath or stabilization of the electrode lead.
Objective: The aim of this study is to investigate whether the type of surgical approach to the cochlea; CO or eRW using the CI632 affects the final residual hearing and secondarily, intracochlear trauma and electrode position, as determined by pure tone audiometry, EcochG and imaging.
Study population: Adult CI candidates with post-lingual onset of severe to profound hearing loss, who are scheduled to receive a Nucleus CI632 with a slim modiolar electrode array and have a preoperative audiometric low-frequency average air conduction threshold of <80 decibel (dB) hearing level at 500 Hz in the ear to be implanted.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Coby Lindeboom, MD
- Phone Number: 024 361 14934
- Email: Coby.lindeboom@radboudumc.nl
Study Contact Backup
- Name: Emmanuel Mylanus
- Email: Emmanuel.Mylanus@radboudumc.nl
Study Locations
-
-
-
Nijmegen, Netherlands
- Recruiting
- Radboud University Medical Center
-
Contact:
- Lindeboom
- Email: Coby.lindeboom@radboudumc.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals aged 18 years and older who have clinically established post-linguistic sensorineural hearing loss.
- CI candidate based on local or national reimbursement criteria.
- Cochlear implantation with a CI632.
- Preoperative 500 Hz pure-tone air conduction threshold <80 dB hearing level (HL) in the ear to be implanted.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Previous or existing CI recipient.
- Ossification or other anatomical abnormalities of the cochlea or its windows possibly affecting normal electrode array insertion.
- Abnormal cochlear nerve anatomy on preoperative CT or MRI.
- Subjects who are unable to undergo CT or MRI.
- Deafness due to acoustic nerve or central auditory pathway lesions.
- Diagnosis of auditory neuropathy.
- Active middle ear infection.
- Additional handicaps that would prevent participation in study evaluations.
- Unrealistic expectations from the participant regarding the possible benefits, risks, and limitations inherent to the CI procedure and the investigation.
- Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Cochleostomy
When employing the cochleostomy approach, a carefully positioned opening will be drilled anterior-inferior to the eRW membrane.
|
Surgical placement of a cochlear implant electrode array
|
|
Active Comparator: extended Round Window
In case of the extended round window approach, the scala tympani will be accessed through the extended round window technique, involving the creation of a round window margin cochleostomy.
|
Surgical placement of a cochlear implant electrode array
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Residual hearing
Time Frame: 3-months postoperatively
|
The difference in residual hearing per group (eRW or CO) between pre- and postoperative pure tone thresholds, averaged at 500, 750 and 1000 Hz (PTAlow).
|
3-months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ECochG thresholds after multiple surgery stages
Time Frame: Intraoperatively
|
ECochG thresholds with a promontory recording electrode after the following surgery stages: a) posterior tympanotomy (baseline), b) drilling for RW membrane exposure, c) completion of the approach to implantation (CO or eRW), d) sheath insertion, e) electrode array insertion, f) sheath withdrawal, and g) positioning of the electrode lead.
|
Intraoperatively
|
|
Intracochlear electrode position
Time Frame: 3-months postoperatively
|
The position of electrode contacts relative to the modiolus and the angular insertion depth (AID), as assessed with pre- and post-operative CT-scan.
|
3-months postoperatively
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL85808.091.23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Sensorineural
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
CochlearCompletedUnilateral Mixed Conductive and Sensorineural Hearing Loss (Diagnosis) | Sensorineural Hearing Loss, Unilateral With Normal Hearing on the Contralateral SideCanada
-
University College, LondonUnknownSensorineural Hearing Loss | Sensory Hearing Loss | Sensorineural Hearing Loss in Left Ear | Sensorineural Hearing Loss in Right Ear | Sensorineural HearingUnited Kingdom
-
Fundación Pública Andaluza para la gestión de la...RecruitingBilateral Sensorineural Hearing Loss | Unilateral Sensorineural Hearing LossSpain
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium
-
Far East Bio-Tec Co., LtdNot yet recruitingTinnitus | Sudden Sensorineural Hearing Loss (SSNHL)Taiwan
-
Assiut UniversityNot yet recruitingSudden Sensorineural Hearing Loss (SSNHL)Egypt
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
Clinical Trials on Surgical approach: cochleostomy or extended round window
-
Odense University HospitalUnknownHearing Loss | Deafness | Sensorineural Hearing LossDenmark
-
UMC UtrechtRecruitingSensorineural Hearing LossNetherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
DePuy InternationalTerminatedOsteoarthritisUnited States, Australia, New Zealand
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Nanfang Hospital... and other collaboratorsNot yet recruitingColorectal Neoplasms
-
AO Clinical Investigation and Publishing DocumentationTerminatedSingle Level Stable Thoracolumbar Fracture Type AO A3 | Multiple Level Stable Thoracolumbar Fracture Type AO A3Brazil, Germany, Chile, Czechia, Italy, Portugal
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPancreatic Adenocarcinoma | Pancreatic Head CancerFrance
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); Lund University; University... and other collaboratorsActive, not recruitingBreast CancerUnited States, Canada, Denmark
-
National Human Genome Research Institute (NHGRI)Sio Gene TherapiesRecruitingGangliosidosis | Lysosomal Diseases | GM1United States
-
University College, LondonSociety for Cardiothoracic Surgery in Great Britain & Ireland; British Congenital...Unknown